Joint swelling in multiple joints

See Doctor Soon

6 studies · 1 recommendation

Last updated: February 14, 2026

Joint swelling in multiple joints – Gout

See Doctor Soon6 studies

Multiple joint swelling in gout signals elevated complication risk requiring prompt medical evaluation

Across 6 studies—including 2 clinical guidelines, 1 systematic review, 1 RCT, 1 cohort study, and 1 nested case-control analysis—polyarticular gout presentation consistently emerges as a marker of more severe disease warranting timely intervention. In a retrospective analysis of 983 gout patients, polyarticular joint distribution independently predicted acute kidney injury (5.6% incidence), with widespread articular involvement amplifying vulnerability to NSAID-related renal complications. A 2-year prospective cohort of 186 patients demonstrated that serum urate fluctuation significantly correlated with flare frequency (p<0.05), reinforcing the value of symptom monitoring. International guidelines from 78 rheumatologists across 14 countries (agreement scores 8.1–9.2/10) and a systematic review of 24 guidance documents both emphasize prompt recognition and management of acute multi-joint flares. Patients experiencing swelling in multiple joints should seek medical evaluation soon to prevent organ damage and optimize treatment timing.

Evidence

Qifu Huazhuo formula for gout recurrence prevention: an interim analysis combining clinical outcomes with proteomic and metabolomic profiling

Authors: Fangjie Zhu, Haiyu Wang, Maojie Wang, Maojie Wang, Maojie Wang, Runyue Huang, Runyue Huang, Runyue Huang, Xiumin Chen, Xiumin Chen, Xiumin Chen, Yongliang Chu, Yongliang Chu, Yongqiang Yang, Yongqiang Yang, Yongqiang Yang, Yunting Xiao, Zhengdong Shen, Zhengdong Shen

Published: October 1, 2025

This randomized controlled trial used frequency of gout attacks as a secondary efficacy endpoint to evaluate treatment effectiveness. Over the 12-week study period, significant differences in gout attack frequency were observed between treatment groups (p = 0.0006), demonstrating that tracking attack recurrence is a clinically meaningful measure of disease management. The study evaluated participants across three treatment arms, establishing that gout flare frequency serves as an actionable metric for patients to monitor their condition.

View Source →

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study

Authors: Berner Hammer, Hilde, Haavardsholm, Espen A., Karoliussen, Lars F., Kvien, Tore K., Pérez Ruiz, Fernando, Sexton, Joe, Uhlig, Till

Published: January 1, 2022

In this 2-year prospective cohort study of gout patients, serum urate fluctuation and change were significantly related to flare occurrence during the first year (both p<0.05). The study tracked flares at monthly and 3-monthly intervals in 186 patients completing year 1 follow-up and 173 at year 2. Fluctuation in serum urate levels was statistically associated with increased flare frequency, making symptom awareness important for timely intervention.

View Source →

Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements

Authors: An, Z, Chen, H, Chen, Y, Chung, S-C, Hemingway, H, Kwong, JS-W, Li, L, Li, Q, Li, S, Li, X, Liu, H, Shah, A, Sun, X, Tian, H, Wang, J

Published: August 24, 2019

The systematic review found concordance among 24 guidance documents regarding first-line treatments for acute gout attacks, indicating clear consensus on the need for prompt management of acute episodes. The review analyzed 16 clinical practice guidelines and 8 consensus statements from international and national/regional sources, with documents published between 2003 and 2017. Guidelines consistently addressed the diagnosis and treatment approach for acute gout manifestations, with high agreement on the clarity of presentation (median 79.2%).

View Source →

Treatment with Allopurinol is Associated with Lower Risk of Acute Kidney Injury in Patients with Gout: A Retrospective Analysis of a Nested Cohort

Authors: Pérez Ruiz, Fernando

Published: January 1, 2017

In the retrospective analysis of 983 gout patients, polyarticular joint distribution was independently associated with higher risk of acute renal events in multivariable Cox survival analysis. The study documented 55 AKI cases (5.6% of cohort), with extensive joint involvement emerging as a significant predictor alongside flare frequency. The RIFLE classification system was used to categorize renal outcomes as risk, injury, or failure, demonstrating that patients with widespread articular manifestations face elevated vulnerability to NSAID-related kidney complications.

View Source →

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative

Authors: Aletaha, Daniel, Andres, Mariano, Bijlsma, Johannes W., Bombardier, Claire, Branco, Jaime C., Buchbinder, Rachelle, Burgos-Vargas, Ruben, Carmona, Loreto, Catrina, Anca I., Edwards, Christopher J., Elewaut, Dirk, Falzon, Louise, Ferrari, Antonio J. L., Kiely, Patrick, Kydd, Alison S. R., Landewe, Robert B., Leeb, Burkhard F., Moi, John, Montecucco, Carlomaurizio, Mueller-Ladner, Ulf, Ostergaard, Mikkel, Seth, Rakhi, Sivera, Francisca, Sriranganathan, Melonie, van der Heijde, Desiree M., van Durme, Caroline, van Echteld, Irene, Vinik, Ophir, Wechalekar, Mihir D., Zochling, Jane

Published: February 1, 2014

The 3e Initiative guideline includes one recommendation specifically addressing gout diagnosis. Developed by 78 international rheumatologists through systematic literature review and formal consensus processes across 14 countries, the diagnostic recommendation helps clinicians and patients identify characteristic gout presentations. Agreement scores across all recommendations ranged from 8.1 to 9.2 (mean 8.7/10). The systematic methodology included independent review by two individuals for data extraction and risk of bias assessment from multiple databases.

View Source →

Italian Society of Rheumatology recommendations for the management of gout.

Authors: Bianchi, G., Borghi, C., Bortoluzzi, A., Cerinic, M. M., Cimmino, M. A., D Avola, G. M., Desideri, G., Di Giacinto, G., Favero, M., Govoni, M., Grassi, W., LEONARDO PUNZI, Lombardi, A., Manara, M., Marangella, M., Medea, G., Minisola, G., Prevete, I., Ramonda, R., Scirè, C. A., Spadaro, A.

Published: January 1, 2013

The Italian Society of Rheumatology guideline addresses management of acute gout attacks, collecting additional evidence on treatment options including oral corticosteroids and low-dose colchicine. The multidisciplinary expert panel recognized that suboptimal management of gout patients remains common despite valid therapeutic options. The guideline emphasizes timely intervention during acute attacks. A research agenda was developed identifying inadequately investigated topics in gout management. The systematic methodology and meta-analysis of RCT data on acute attack management underscore the importance of recognizing flare symptoms for prompt appropriate treatment.

View Source →